AR and posterior cortical atrophy: In addition to KDM1A, KDM3A[94], KDM4A/4B[98-101], and KDM6A/6B[102] were also identified as coactivators of AR and play critical roles in PCa progression, thus characterizing them as potential therapeutic targets.